These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Granulocyte-colony-stimulating factor induces increased serum levels of soluble interleukin 2 receptors preceding engraftment in autologous bone marrow transplantation. Dreger P, Grelle K, Eckstein V, Suttorp M, Müller-Ruchholtz W, Löffler H, Schmitz N. Br J Haematol; 1993 Jan; 83(1):7-13. PubMed ID: 7679589 [Abstract] [Full Text] [Related]
5. Elevated concentration of soluble interleukin-2 receptors in serum of smokers and patients with lung cancer. Correlation with clinical activity. Ginns LC, De Hoyos A, Brown MC, Gaumond BR. Am Rev Respir Dis; 1990 Aug; 142(2):398-402. PubMed ID: 2200317 [Abstract] [Full Text] [Related]
13. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients]. Higuchi Y. Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690 [Abstract] [Full Text] [Related]
20. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer. Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N. Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282 [Abstract] [Full Text] [Related] Page: [Next] [New Search]